Le Lézard
Classified in: Business, Covid-19 virus
Subject: AVO

Joint Statement - CMC & BCCA


Sale of Mountain Equipment Co-op

OTTAWA, ON, Sept. 15, 2020 /CNW/ - On this International Day of Democracy, Co-operatives and Mutuals Canada (CMC) and the British Columbia Co-op Association (BCCA) are disappointed by the developments surrounding Mountain Equipment Co-op, which has long been Canada's largest consumer co-operative and a valued member of CMC.

"Co-operatives and mutuals have been our most resilient business model for over a century because of their values and principles, enabling democratic control by members and their focus on the sustainable development of their communities," said John Kay, Chair of CMC's Board of Directors and Vice-Chair of the BCCA Board of Directors.

Today there are more than 8,000 co-operatives and mutuals in Canada that proudly represent 3.4% of Canada's gross domestic product (GDP). These co-operatives and mutuals support Canadians through financial and insurance services, housing, farming, food processing, childcare, seniors care, paramedic services, retail, and in many other sectors of our economy. Together, Canada's co-operatives and mutuals represent a volume of business worth more than $85 billion per year and provide employment to nearly 200,000 Canadians.

As stated in a 2019 report issued by the Government of Canada ? "Co-operatives have high growth projections, including intentions to expand to new markets, over the next three years and are more likely than small and medium-sized enterprises (SMEs) to develop new innovations. Co-operatives also have diverse ownership, with a strong percentage of the businesses owned by women and Indigenous peoples and they are very mature with an average business age of 43.7 years."

"Despite the extraordinary hardships caused by the COVID-19 pandemic, co-operatives and mutuals remain a strong and reliable business model that serve Canadians in every facet of the economy. If you're looking for a sustainable business model, we certainly have one," said André Beaudry, CMC Executive Director.

Both CMC and BCCA call on the Governments of Canada and British Columbia to confirm that provincial and federal legislation has been fully respected allowing the sale of this iconic Canadian co-op retailer to a foreign entity, and that the best interests of MEC members, employees, and the communities they serve are being given full consideration. CMC and BCCA will continue to monitor the sale and consider appropriate interventions.

CMC and BCCA will continue to support their members through good times and bad and advocate for the continued growth and expansion of co-operatives and mutuals. Canadian society is better and more equitable with a healthy and robust co-operative and mutual sector that espouses values and principles that lead to sustainable employment, businesses and communities. 

SOURCE Co-operatives and Mutuals Canada


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIOŽ (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: